Guidelines for Laboratory Diagnosis of Coronavirus Disease 2019 (COVID-19) in Korea

Area of Science:

• Clinical Microbiology
• Infectious Diseases
• Public Health

Background:

• The coronavirus disease 2019 (COVID-19) pandemic, caused by SARS-CoV-2, presented a significant public health challenge globally and in Korea.
• As of March 25, 2020, Korea reported over 9,000 confirmed COVID-19 cases, necessitating standardized diagnostic protocols.
• Real-time reverse transcription-PCR (RT-PCR) is the established gold standard for detecting SARS-CoV-2.

Purpose of the Study:

• To establish comprehensive guidelines for the diagnosis of COVID-19 within Korean clinical laboratory settings.
• To provide a standardized framework for healthcare professionals involved in COVID-19 testing and diagnosis.
• To ensure accurate and reliable detection of SARS-CoV-2 infections.

Main Methods:

• Development of guidelines based on existing domestic and international protocols.
• Inclusion of expert opinions from the Korean Society for Laboratory Medicine and the Korea Centers for Disease Prevention and Control.
• Detailed recommendations covering test subject selection, specimen collection, diagnostic methodologies, result interpretation, and biosafety measures.

Main Results:

• The guidelines provide a structured approach to COVID-19 diagnosis in clinical laboratories.
• Standardized procedures are outlined for RT-PCR testing, specimen handling, and result interpretation.
• Emphasis is placed on critical biosafety practices for laboratory personnel handling SARS-CoV-2 samples.

Conclusions:

• The proposed guidelines aim to enhance the accuracy and efficiency of COVID-19 diagnostics in Korea.
• Adherence to these guidelines is expected to improve patient management and public health surveillance for SARS-CoV-2.
• These recommendations serve as a vital resource for clinical laboratories navigating the COVID-19 pandemic.